Technology offer : Leptospirosis Diagnostic
Leptospirosis is a growing public health concern in many tropical and subtropical countries. However, its diagnosis is difficult because of non-specific symptoms and concurrent other endemic diseases. In many regions the laboratory diagnosis is not available due to a lack of preparedness and simple diagnostic assay or difficult access to references laboratories. The technology developed within the Pasteur Institute refers to the use of a new antigen for the detection of anti-leptospira human IgM. The technology has been developed in ELISA and Vertical flow rapid diagnostic test (RDT). First tries gives for ELISA a sensitivity of 94% and specificity of 99%, and the RDT shows a sensitivity of 90% and specificity of 94%. Domestic and farm animals are also very susceptible to leptospira bacteria. The technology could be easily developed for animal diagnosis.
Ref : OT-00006
Area of activity : HEALTH COSMETOLOGY
P: +33 (0) 491 999 456